Cheetah Therapeutics® is accelerating treatments to patients with cancer.
Cheetah Therapeutics®
Cheetahs chase their prey at average speeds of 60 miles per hour. Cheetah TherapeuticsTM is our first start-up. The firm is licensing clinical molecules from large pharma to develop and register for use by patients who need them. With our expertise and agility, we believe we can match the speeds of any Cheetah.
Cheetah Therapeutics(R) has been established as a Delaware C Corporation.